glp 1 drugs and cancer GLP-1 Receptor Agonists Show a Striking Signal in Breast Outcomes, but Big Questions Remain GLP-1 drugs linked to major

As the wealth of research continues to evolve, ongoing and future trials will help refine the role of GLP-1 RAs in a broader range of conditions and chart new therapies for the next generation of cardiovascular care

doi: 10.3389/fnins.2019.01112 9 GaoHZengZZhangHZhouXGuanLDengWet al

doi: 10.1001/jama.2021.23619

Saxenda is safe and effective for most adults and children

It comes in a single-use self-injectable pen that you take once per week

Convergence with Combination Biology Dual and multi-agonist molecules combining GLP-1 activity with GIP and/or glucagon receptor activity are emerging and driving superior metabolic efficacy in clinical studies